Shasun Pharmaceuticals (SHASUNPHAR) Share Discussion | Stock forum

Shasun Pharmaceuticals

Shasun Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and enteric coating excipients.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$SHASUNPHAR	BSE	INE317A01028	Code: 524552
$SHASUNPHAR	NSE	INE317A01028

Recent news

Fertilizers & Chemicals Travancore reports 2,795% EBITDA growth in 2020 and 9.6 pp EBITDA Margin growth from 0.49% to 10.1%

Ginni Filaments EBITDA jumped on 15.6% while Revenue decreased slightly on 1.3%

Ajel Net Income dropped on 148% while EBITDA Margin increased on 3.9 pp from -11.7% to -7.8%

Gulf Oil Corporation Net Debt / EBITDA jumped on 70.0x from 5.2x to 75.2x in 2020 while Revenue decreased on 6.3%

Royal Orchid Hotels Net Income dropped on 58.9% and Revenue increased slightly on 0.59%

Media Matrix Worldwide Net Income dropped on 95.2% and Revenue dropped on 31.1%

Sindhu Trade Links reports 250% Net Income growth in 2020 while 58.9% Revenue decline

Jay Shree Tea & Industries reports 318% EBITDA decline in 2020 and 5.2% Revenue decline

Hexaware Technologies revenue jumped on 20.1% and EBITDA Margin showed almost no change

Fertilizers & Chemicals Travancore Net Debt / EBITDA jumped on 221.9x from 13.3x to 235.2x in 2019 and Revenue increased slightly on 1.3%

Twit about SHASUNPHAR stock

Share your investment idea or question on Shasun Pharmaceuticals stock:

Latest twits on Shasun Pharmaceuticals (SHASUNPHAR)

No twits yet. Be the first to post!

Have a question about SHASUNPHAR? Ask and other investors will be eager to help you.

Have an idea about SHASUNPHAR? Share it with other investors.

Shasun Pharmaceuticals news

30-04-2015 Shasun Pharmaceuticals CAPEX dropped on 22.5% in 2015 while Revenue increased on 8.6%

Shasun Pharmaceuticals stock price chart

Shasun Pharmaceuticals financials

mln. INR	FY2010	FY2011	FY2012

Revenue	15,604	8,345	10,664
EBITDA	904.1	714.7	1,230
Net income	37.670	266.2	1,006
CAPEX	210.7	355.1	1,109
Debt	3,266	3,290	3,530
Cash	95.480	88.430	139.9

Shasun Pharmaceuticals news

30-04-2015 Shasun Pharmaceuticals CAPEX dropped on 22.5% in 2015 while Revenue increased on 8.6%

About Shasun Pharmaceuticals

Shasun Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and enteric coating excipients. The company offers API products in the areas of pain management and musculoskeletal, central nervous system, cardiovascular, hyperphosphataemia, anti-infective, gastrointestinal, gastrointestinal, and other areas, as well as is developing API products in the areas of anti-depressant and anti-Parkinson